Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
57.98
Dollar change
+2.14
Percentage change
3.83
%
IndexRUT P/E- EPS (ttm)-5.39 Insider Own3.33% Shs Outstand118.01M Perf Week11.89%
Market Cap7.10B Forward P/E- EPS next Y-5.36 Insider Trans-5.95% Shs Float114.09M Perf Month9.09%
Income-576.40M PEG- EPS next Q-1.29 Inst Own113.71% Short Float13.62% Perf Quarter3.20%
Sales3.22M P/S2206.43 EPS this Y2.60% Inst Trans14.46% Short Ratio13.15 Perf Half Y-6.63%
Book/sh-0.12 P/B- EPS next Y-0.99% ROA-52.96% Short Interest15.54M Perf Year66.80%
Cash/sh8.26 P/C7.02 EPS next 5Y15.00% ROE- 52W Range30.68 - 110.25 Perf YTD-30.55%
Dividend Est.- P/FCF- EPS past 5Y-22.79% ROI-77.33% 52W High-47.41% Beta0.82
Dividend TTM- Quick Ratio9.28 Sales past 5Y12.30% Gross Margin-318.86% 52W Low88.98% ATR (14)1.93
Dividend Ex-Date- Current Ratio9.28 EPS Y/Y TTM2.40% Oper. Margin-16297.79% RSI (14)65.98 Volatility4.20% 3.20%
Employees423 Debt/Eq- Sales Y/Y TTM-58.81% Profit Margin-17906.24% Recom1.53 Target Price81.29
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q-1.26% Payout- Rel Volume1.46 Prev Close55.84
Sales Surprise-61.86% EPS Surprise-10.16% Sales Q/Q22.49% EarningsNov 06 AMC Avg Volume1.18M Price57.98
SMA208.23% SMA507.18% SMA200-4.56% Trades Volume1,719,817 Change3.83%
Date Action Analyst Rating Change Price Target Change
Nov-08-24Initiated RBC Capital Mkts Outperform $80
Aug-13-24Downgrade Goldman Buy → Neutral $85 → $60
Jan-24-24Downgrade UBS Buy → Neutral $61 → $92
Jan-05-24Downgrade Morgan Stanley Overweight → Equal-Weight $60 → $90
Nov-09-23Initiated Goldman Buy $50
Nov-07-23Initiated B. Riley Securities Buy $66
Aug-15-23Initiated SVB Securities Outperform $58
Feb-17-23Initiated BofA Securities Neutral $49
Dec-23-22Reiterated Needham Buy $60 → $58
Dec-20-22Initiated Truist Buy $60
Nov-07-24 04:01AM
Nov-06-24 05:05PM
04:06PM
04:00PM
Nov-05-24 04:00PM
07:38AM Loading…
07:38AM
Nov-04-24 04:00PM
Oct-23-24 04:00PM
Oct-16-24 04:07PM
07:30AM
Oct-09-24 05:54PM
Oct-03-24 04:00PM
Oct-02-24 04:00PM
Oct-01-24 04:30AM
Sep-30-24 09:20AM
11:00AM Loading…
Sep-27-24 11:00AM
Sep-24-24 07:30AM
Sep-19-24 04:08PM
04:00PM
09:22AM
Sep-09-24 01:11PM
07:30AM
Sep-08-24 01:55AM
Sep-05-24 04:00PM
Sep-04-24 04:00PM
01:16AM
Sep-01-24 04:27AM
03:51AM
Aug-29-24 04:00PM
Aug-22-24 07:01PM
10:20AM Loading…
Aug-09-24 10:20AM
Aug-08-24 09:59PM
05:10PM
04:13PM
04:00PM
01:01AM
Aug-01-24 04:00PM
Jul-30-24 07:30AM
Jul-25-24 04:00PM
10:01AM
Jul-23-24 07:01PM
Jul-17-24 08:00AM
Jul-16-24 07:30AM
Jul-11-24 08:00AM
08:00AM
Jul-10-24 01:42AM
Jul-03-24 04:00PM
Jul-02-24 02:46AM
Jun-26-24 02:11PM
Jun-18-24 01:49AM
Jun-17-24 07:30AM
Jun-12-24 02:37AM
Jun-10-24 07:00PM
Jun-05-24 07:55AM
06:14AM
03:00AM
Jun-04-24 04:00PM
02:38AM
May-29-24 04:00PM
May-28-24 04:00PM
May-27-24 06:28PM
06:13PM
May-24-24 11:12AM
May-23-24 09:40AM
07:50AM
May-22-24 11:30PM
04:10PM
04:02PM
04:00PM
May-17-24 07:30AM
May-15-24 07:30AM
May-14-24 04:01PM
May-13-24 05:24PM
04:08PM
09:43AM
09:33AM
09:33AM
09:11AM
May-10-24 12:37PM
May-09-24 10:48AM
10:46AM
07:01AM
May-08-24 09:00PM
05:18PM
05:10PM
04:06PM
04:00PM
07:30AM
07:30AM
02:23AM
May-07-24 05:02PM
04:00PM
02:04PM
May-02-24 04:00PM
May-01-24 10:01AM
Apr-29-24 04:00PM
Apr-26-24 04:44PM
06:00AM
Apr-24-24 04:00PM
Apr-10-24 09:27AM
Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Blum Robert IPresident & CEONov 01 '24Option Exercise6.675,00033,350402,456Nov 04 05:45 PM
Blum Robert IPresident & CEONov 01 '24Sale51.635,000258,150397,456Nov 04 05:45 PM
ROBERT BLUMOfficerNov 01 '24Proposed Sale51.635,000258,158Nov 01 04:43 PM
WIERENGA WENDALLDirectorOct 28 '24Option Exercise7.374,45232,81129,011Oct 31 04:49 PM
WIERENGA WENDALLDirectorOct 28 '24Sale52.254,452232,61724,559Oct 31 04:49 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 30 '24Option Exercise7.965,30042,188122,220Oct 31 04:45 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 30 '24Sale51.917,300378,930114,920Oct 31 04:45 PM
FADY MALIKOfficerOct 29 '24Proposed Sale51.917,300378,939Oct 29 04:08 PM
WENDELL WIERENGADirectorOct 28 '24Proposed Sale52.254,452232,617Oct 28 04:12 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 15 '24Option Exercise7.965,30042,188124,220Oct 16 06:45 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 15 '24Sale54.197,300395,554116,920Oct 16 06:45 PM
FADY MALIKOfficerOct 15 '24Proposed Sale54.197,300395,578Oct 15 04:32 PM
Blum Robert IPresident & CEOOct 09 '24Option Exercise6.675,00033,350402,456Oct 10 04:00 PM
Blum Robert IPresident & CEOOct 09 '24Sale55.615,000278,050397,456Oct 10 04:00 PM
ROBERT BLUMOfficerOct 09 '24Proposed Sale55.615,000278,062Oct 09 04:08 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 01 '24Option Exercise7.965,30042,188124,220Oct 01 04:48 PM
Malik Fady IbrahamEVP Research & DevelopmentOct 01 '24Sale52.107,300380,297118,920Oct 01 04:48 PM
FADY MALIKOfficerOct 01 '24Proposed Sale52.107,300380,318Oct 01 04:21 PM
Blum Robert IPresident & CEOSep 30 '24Option Exercise6.675,00033,350402,456Sep 30 06:56 PM
Blum Robert IPresident & CEOSep 30 '24Sale52.145,000260,700397,456Sep 30 06:56 PM
ROBERT BLUMOfficerSep 30 '24Proposed Sale52.145,000260,698Sep 30 04:06 PM
Malik Fady IbrahamEVP Research & DevelopmentSep 17 '24Option Exercise7.965,30042,188128,220Sep 17 04:15 PM
Malik Fady IbrahamEVP Research & DevelopmentSep 17 '24Sale56.777,300414,401120,920Sep 17 04:15 PM
Blum Robert IPresident & CEOSep 16 '24Option Exercise6.675,00033,350402,456Sep 17 04:10 PM
Blum Robert IPresident & CEOSep 16 '24Sale55.995,000279,950397,456Sep 17 04:10 PM
FADY MALIKOfficerSep 17 '24Proposed Sale56.777,300414,401Sep 17 04:03 PM
ROBERT BLUMOfficerSep 16 '24Proposed Sale55.995,000279,962Sep 16 04:29 PM
B LYNNE PARSHALLDirectorSep 09 '24Proposed Sale54.925,000274,582Sep 09 04:12 PM
PARSHALL B LYNNEDirectorSep 09 '24Option Exercise21.615,000108,05025,600Sep 09 04:05 PM
PARSHALL B LYNNEDirectorSep 09 '24Sale54.925,000274,60020,600Sep 09 04:05 PM
Malik Fady IbrahamEVP Research & DevelopmentSep 03 '24Option Exercise7.965,30042,188128,220Sep 03 05:14 PM
Malik Fady IbrahamEVP Research & DevelopmentSep 03 '24Sale57.017,384420,973122,920Sep 03 05:14 PM
Blum Robert IPresident & CEOSep 03 '24Option Exercise6.675,00033,350402,456Sep 03 05:09 PM
Blum Robert IPresident & CEOSep 03 '24Sale57.035,000285,150397,456Sep 03 05:09 PM
ROBERT BLUMOfficerSep 03 '24Proposed Sale57.035,000285,126Sep 03 04:08 PM
FADY MALIKOfficerSep 03 '24Proposed Sale57.017,384420,973Sep 03 04:07 PM
B LYNNE PARSHALLDirectorAug 26 '24Proposed Sale57.265,000286,288Aug 26 04:14 PM
PARSHALL B LYNNEDirectorAug 26 '24Option Exercise21.615,000108,05025,600Aug 26 04:00 PM
PARSHALL B LYNNEDirectorAug 26 '24Sale57.265,000286,30020,600Aug 26 04:00 PM
Malik Fady IbrahamEVP Research & DevelopmentAug 20 '24Option Exercise7.965,30042,188130,304Aug 22 04:00 PM
Malik Fady IbrahamEVP Research & DevelopmentAug 20 '24Sale56.257,300410,638125,004Aug 22 04:00 PM
FADY MALIKOfficerAug 20 '24Proposed Sale56.267,300410,669Aug 20 04:08 PM
Blum Robert IPresident & CEOAug 12 '24Option Exercise6.6711,50076,705410,912Aug 12 05:32 PM
Blum Robert IPresident & CEOAug 12 '24Sale55.1711,500634,455399,412Aug 12 05:32 PM
PARSHALL B LYNNEDirectorAug 12 '24Option Exercise21.615,000108,05025,600Aug 12 05:31 PM
PARSHALL B LYNNEDirectorAug 12 '24Sale55.205,000276,00020,600Aug 12 05:31 PM
B LYNNE PARSHALLDirectorAug 12 '24Proposed Sale55.205,000276,007Aug 12 04:24 PM
ROBERT BLUMOfficerAug 12 '24Proposed Sale55.1711,500634,470Aug 12 04:21 PM
Malik Fady IbrahamEVP Research & DevelopmentAug 07 '24Option Exercise7.965,30042,188127,004Aug 07 08:06 PM
Malik Fady IbrahamEVP Research & DevelopmentAug 06 '24Sale53.717,300392,090121,704Aug 07 08:06 PM
FADY MALIKOfficerAug 06 '24Proposed Sale53.717,300392,096Aug 06 04:14 PM
PARSHALL B LYNNEDirectorJul 29 '24Option Exercise21.615,000108,05025,600Jul 31 04:39 PM
PARSHALL B LYNNEDirectorJul 29 '24Sale59.845,000299,20020,600Jul 31 04:39 PM
Blum Robert IPresident & CEOJul 30 '24Option Exercise6.6711,50076,705410,912Jul 31 04:36 PM
Blum Robert IPresident & CEOJul 30 '24Sale59.4911,500684,135399,412Jul 31 04:36 PM
ROBERT BLUMOfficerJul 30 '24Proposed Sale59.4911,500684,158Jul 30 04:13 PM
B LYNNE PARSHALLDirectorJul 29 '24Proposed Sale59.845,000299,217Jul 29 04:17 PM
Malik Fady IbrahamEVP Research & DevelopmentJul 23 '24Option Exercise7.965,30042,188134,304Jul 23 04:47 PM
Malik Fady IbrahamEVP Research & DevelopmentJul 23 '24Sale57.027,300416,246129,004Jul 23 04:47 PM
PARSHALL B LYNNEDirectorJul 15 '24Option Exercise10.685,00053,40025,600Jul 16 05:05 PM
PARSHALL B LYNNEDirectorJul 15 '24Sale55.825,000279,10020,600Jul 16 05:05 PM
Blum Robert IPresident & CEOJul 10 '24Option Exercise6.675,76738,466410,912Jul 10 05:24 PM
Blum Robert IPresident & CEOJul 10 '24Sale54.2911,500624,335399,412Jul 10 05:24 PM
Malik Fady IbrahamEVP Research & DevelopmentJul 09 '24Option Exercise7.965,30042,188138,304Jul 09 06:15 PM
Malik Fady IbrahamEVP Research & DevelopmentJul 09 '24Sale55.907,300408,103131,004Jul 09 06:15 PM
Harrington Robert ArthurDirectorJul 05 '24Sale54.6125313,81615,516Jul 08 05:06 PM
PARSHALL B LYNNEDirectorJul 01 '24Option Exercise10.685,00053,40025,600Jul 01 05:12 PM
PARSHALL B LYNNEDirectorJul 01 '24Sale54.225,000271,10020,600Jul 01 05:12 PM
Blum Robert IPresident & CEOJul 01 '24Sale54.0511,500621,575405,145Jul 01 05:04 PM
Malik Fady IbrahamEVP Research & DevelopmentJun 25 '24Option Exercise7.965,30042,188138,304Jun 25 08:04 PM
Malik Fady IbrahamEVP Research & DevelopmentJun 25 '24Sale53.727,300392,143133,004Jun 25 08:04 PM
PARSHALL B LYNNEDirectorJun 17 '24Option Exercise10.685,00053,40025,600Jun 17 05:17 PM
PARSHALL B LYNNEDirectorJun 17 '24Sale52.555,000262,75020,600Jun 17 05:17 PM
Blum Robert IPresident & CEOJun 17 '24Sale52.6022,5001,183,391416,645Jun 17 05:13 PM
Malik Fady IbrahamEVP Research & DevelopmentJun 11 '24Option Exercise7.965,42243,159142,792Jun 11 04:22 PM
Malik Fady IbrahamEVP Research & DevelopmentJun 11 '24Sale53.047,788413,106135,004Jun 11 04:22 PM
Bhanji MunaDirectorJun 10 '24Sale52.072,000104,14017,631Jun 10 04:15 PM
Blum Robert IPresident & CEOJun 04 '24Sale48.8522,5001,099,125439,145Jun 07 04:03 PM
Harrington Robert ArthurDirectorJun 03 '24Sale48.641,58076,85115,541Jun 05 05:23 PM
PARSHALL B LYNNEDirectorJun 03 '24Option Exercise10.685,00053,40020,600Jun 04 04:30 PM
PARSHALL B LYNNEDirectorJun 03 '24Sale48.645,000243,20015,600Jun 04 04:30 PM
Wong RobertVP, Chief Accounting OfficerJun 03 '24Sale48.8813,011635,97816,653Jun 03 04:33 PM
Malik Fady IbrahamEVP Research & DevelopmentMay 07 '24Option Exercise6.6714,18694,621152,603May 07 04:37 PM
Malik Fady IbrahamEVP Research & DevelopmentMay 07 '24Sale65.1115,5471,012,265137,056May 07 04:37 PM
HENDERSON JOHN TDirectorApr 25 '24Sale64.5410,562681,67132,070Apr 25 06:54 PM
Malik Fady IbrahamEVP Research & DevelopmentApr 09 '24Option Exercise6.6728,605190,795171,172Apr 09 04:38 PM
Malik Fady IbrahamEVP Research & DevelopmentApr 09 '24Sale74.3132,6052,422,918138,567Apr 09 04:38 PM
Malik Fady IbrahamEVP Research & DevelopmentMar 05 '24Option Exercise6.6728,604190,789167,577Mar 05 04:05 PM
Malik Fady IbrahamEVP Research & DevelopmentMar 05 '24Sale67.5632,6042,202,606138,973Mar 05 04:05 PM
HENDERSON JOHN TDirectorFeb 14 '24Option Exercise4.445,00022,20047,632Feb 14 04:04 PM
HENDERSON JOHN TDirectorFeb 14 '24Sale76.485,000382,40042,632Feb 14 04:04 PM
Blum Robert IPresident & CEOFeb 13 '24Option Exercise6.6712,50083,375454,297Feb 13 04:01 PM
Blum Robert IPresident & CEOFeb 13 '24Sale76.8512,500960,625441,797Feb 13 04:01 PM
Malik Fady IbrahamEVP Research & DevelopmentFeb 06 '24Option Exercise6.6728,605190,795175,578Feb 06 04:43 PM
Malik Fady IbrahamEVP Research & DevelopmentFeb 06 '24Sale79.3032,6052,585,496142,973Feb 06 04:43 PM
Blum Robert IPresident & CEOJan 31 '24Option Exercise6.6712,50083,375454,297Feb 02 04:41 PM
Blum Robert IPresident & CEOJan 31 '24Sale79.5712,500994,625441,797Feb 02 04:41 PM
Blum Robert IPresident & CEOJan 19 '24Option Exercise6.6712,50083,375454,297Jan 22 05:19 PM
Blum Robert IPresident & CEOJan 19 '24Sale81.4212,5001,017,750441,797Jan 22 05:19 PM
HENDERSON JOHN TDirectorJan 12 '24Option Exercise4.445,00022,20047,632Jan 12 05:20 PM